111 Capital Buys Shares of 935 Waters Corporation $WAT

Key Points

• 111 Capital has acquired 935 shares of Waters Corporation (NYSE:WAT), valuing the stake at approximately $326,000.
• Institutional investors own 94.01% of Waters Corporation's stock, with major increases from entities such as Brighton Jones LLC and Procyon Advisors LLC.
• Waters reported earnings of $2.95 per share for the last quarter, surpassing estimates, with revenue increasing 8.8% year-over-year to $771.33 million.

111 Capital bought a new stake in Waters Corporation (NYSE:WAT - Free Report) in the second quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The fund bought 935 shares of the medical instruments supplier's stock, valued at approximately $326,000.

A number of other institutional investors and hedge funds have also recently added to or reduced their stakes in the business. Brighton Jones LLC boosted its position in shares of Waters by 112.9% during the fourth quarter. Brighton Jones LLC now owns 1,269 shares of the medical instruments supplier's stock worth $471,000 after buying an additional 673 shares during the period. Procyon Advisors LLC boosted its position in shares of Waters by 19.6% during the first quarter. Procyon Advisors LLC now owns 1,189 shares of the medical instruments supplier's stock worth $438,000 after buying an additional 195 shares during the period. Fenimore Asset Management Inc boosted its position in shares of Waters by 0.4% during the first quarter. Fenimore Asset Management Inc now owns 234,488 shares of the medical instruments supplier's stock worth $86,425,000 after buying an additional 1,011 shares during the period. Pallas Capital Advisors LLC acquired a new position in shares of Waters during the first quarter worth about $218,000. Finally, GAMMA Investing LLC boosted its position in shares of Waters by 36.6% during the first quarter. GAMMA Investing LLC now owns 1,797 shares of the medical instruments supplier's stock worth $662,000 after buying an additional 481 shares during the period. 94.01% of the stock is owned by institutional investors and hedge funds.

Wall Street Analyst Weigh In

Several research firms have recently weighed in on WAT. Wall Street Zen cut Waters from a "buy" rating to a "hold" rating in a research report on Saturday, July 26th. Bank of America upped their price objective on Waters from $370.00 to $375.00 and gave the stock a "neutral" rating in a research report on Thursday, June 26th. Robert W. Baird reduced their price objective on Waters from $374.00 to $352.00 and set an "outperform" rating for the company in a research report on Wednesday, July 16th. UBS Group reissued a "neutral" rating on shares of Waters in a research report on Tuesday, July 15th. Finally, Scotiabank reaffirmed a "sector outperform" rating and set a $465.00 price target on shares of Waters in a research report on Friday, July 11th. One investment analyst has rated the stock with a Strong Buy rating, five have assigned a Buy rating and nine have assigned a Hold rating to the company's stock. According to data from MarketBeat.com, the company currently has a consensus rating of "Hold" and a consensus price target of $380.43.

Waters Trading Down 0.0%

Shares of Waters stock opened at $328.29 on Tuesday. Waters Corporation has a 12-month low of $275.05 and a 12-month high of $423.56. The stock has a market cap of $19.54 billion, a P/E ratio of 29.60, a P/E/G ratio of 3.06 and a beta of 1.04. The company has a quick ratio of 1.22, a current ratio of 1.75 and a debt-to-equity ratio of 0.55. The business's 50 day moving average is $297.43 and its 200-day moving average is $324.75.

Waters (NYSE:WAT - Get Free Report) last released its quarterly earnings data on Monday, August 4th. The medical instruments supplier reported $2.95 earnings per share (EPS) for the quarter, beating the consensus estimate of $2.93 by $0.02. Waters had a return on equity of 38.60% and a net margin of 21.71%.The firm had revenue of $771.33 million for the quarter, compared to analyst estimates of $745.96 million. During the same quarter in the prior year, the company earned $2.63 earnings per share. The business's revenue for the quarter was up 8.8% compared to the same quarter last year. Waters has set its Q3 2025 guidance at 3.150-3.250 EPS. FY 2025 guidance at 12.950-13.050 EPS. Equities research analysts predict that Waters Corporation will post 12.86 earnings per share for the current fiscal year.

Waters Profile

Waters Corporation provides analytical workflow solutions in Asia, the Americas, and Europe. It operates through two segments: Waters and TA. The company designs, manufactures, sells, and services high and ultra-performance liquid chromatography, as well as mass spectrometry (MS) technology systems and support products, including chromatography columns, other consumable products, and post-warranty service plans.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.